Clinical trial Recruiting at 1 site Interventional Ages 20 to 80

Using shock wave and electromagnetic therapies to treat lymphedema

Official title: Effects of Extracorporeal Shock Wave Therapy and Pulse Electromagnetic Field Therapy on Lymphoedema

Run by Kaohsiung Veterans General Hospital. · NCT06041958 · Data updated 2026-11-12

This study is testing if shock wave and electromagnetic therapies can help people with lymphedema reduce swelling and improve their condition over a year.

Quick facts

Study typeInterventional
Ages20 Years to 80 Years
SexAll
Enrollment90 (estimated)
SponsorKaohsiung Veterans General Hospital.
Academic / other
Locations1 site (Kaohsiung City)
StatusRecruiting
StartedOctober 8, 2021
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedMarch 31, 2026
Trial IDNCT06041958 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 20 and older with lymphedema resulting from breast or gynecological cancer treatments.

Probably not a fit

Patients with open wounds, acute infections, or severe clotting abnormalities in the affected limb may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effects of extracorporeal shock wave therapy (ESWT) and pulse electromagnetic field therapy (PEMFT) on patients suffering from lymphedema, a condition characterized by limb swelling due to lymphatic fluid accumulation. The research aims to explore the therapeutic benefits of these treatments, which have shown promise in other medical applications. Participants will undergo these therapies and be monitored for changes in their condition over a 12-month period. The study seeks to provide insights into effective management strategies for lymphedema, which currently lacks definitive treatment options.

Why it matters

Potential benefit: If successful, this study could offer new therapeutic options for patients with lymphedema, improving their quality of life.

How similar studies have gone: Previous studies have shown promising results for similar therapies in treating lymphedema, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants must be at least 20 years old and have no significant cognitive, language comprehension, or communication issues, be able to understand and follow instructions, and sign the informed consent form.
* Individuals with lymphedema after treatment for breast cancer or gynecologic cancer are eligible (lymphedema is defined as a circumference difference of \>2 cm in the same location on both limbs).
* You must be able to attend follow-up appointments at specific times during the 12 months of the trial, referred by a rehabilitation physician in the outpatient department.

Exclusion Criteria:

* The affected limb has unhealed open wounds, acute infections, or other conditions unsuitable for contact-based treatment.
* The affected limb has metastatic tumors.
* The affected limb has untreated deep vein thrombosis.
* Severe clotting abnormalities.

Where it's running

  • Kaohsiung Veterans General Hospital
    Kaohsiung City, Taiwan
    Recruiting

Study contacts

  • Principal investigator: Zheng Yu Hoe, MD.,PhD. — Kaohsiung Veterans General Hospital.
  • Study coordinator: Zheng Yu Hoe, MD.,PhD.
  • Email: jhoe@vghks.gov.tw
  • Phone: +886935517631

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.